TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 234 filers reported holding TG THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 1.18 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,134,570 | -65.8% | 135,714 | +1.7% | 0.00% | -100.0% |
| Q2 2023 | $3,313,631 | +77.5% | 133,399 | +7.5% | 0.00% | 0.0% |
| Q1 2023 | $1,867,020 | +38.4% | 124,137 | +8.8% | 0.00% | 0.0% |
| Q4 2022 | $1,349,235 | +83.3% | 114,052 | -8.3% | 0.00% | – |
| Q3 2022 | $736,000 | +22.9% | 124,356 | -11.8% | 0.00% | – |
| Q2 2022 | $599,000 | -42.5% | 140,981 | +28.8% | 0.00% | – |
| Q1 2022 | $1,041,000 | -49.9% | 109,452 | +0.1% | 0.00% | -100.0% |
| Q4 2021 | $2,078,000 | -42.7% | 109,371 | +0.3% | 0.00% | 0.0% |
| Q3 2021 | $3,629,000 | +17.9% | 109,043 | +37.5% | 0.00% | 0.0% |
| Q2 2021 | $3,077,000 | -17.7% | 79,304 | +2.2% | 0.00% | 0.0% |
| Q1 2021 | $3,740,000 | -4.1% | 77,593 | +3.5% | 0.00% | -50.0% |
| Q4 2020 | $3,899,000 | +137.0% | 74,948 | +21.9% | 0.00% | +100.0% |
| Q3 2020 | $1,645,000 | +260.0% | 61,458 | +161.8% | 0.00% | – |
| Q2 2020 | $457,000 | +114.6% | 23,475 | +8.3% | 0.00% | – |
| Q1 2020 | $213,000 | -24.2% | 21,675 | -14.5% | 0.00% | – |
| Q4 2019 | $281,000 | +136.1% | 25,359 | +19.9% | 0.00% | – |
| Q3 2019 | $119,000 | -22.2% | 21,156 | +19.6% | 0.00% | – |
| Q2 2019 | $153,000 | +86.6% | 17,682 | +73.6% | 0.00% | – |
| Q1 2019 | $82,000 | +95.2% | 10,185 | 0.0% | 0.00% | – |
| Q4 2018 | $42,000 | -26.3% | 10,185 | 0.0% | 0.00% | – |
| Q3 2018 | $57,000 | -53.3% | 10,185 | +9.6% | 0.00% | – |
| Q2 2018 | $122,000 | -10.3% | 9,291 | -2.9% | 0.00% | – |
| Q1 2018 | $136,000 | +19.3% | 9,566 | -29.4% | 0.00% | – |
| Q4 2017 | $114,000 | -23.0% | 13,559 | +8.5% | 0.00% | – |
| Q3 2017 | $148,000 | +29.8% | 12,500 | +11.0% | 0.00% | – |
| Q2 2017 | $114,000 | +0.9% | 11,264 | +14.9% | 0.00% | – |
| Q1 2017 | $113,000 | +156.8% | 9,801 | +4.1% | 0.00% | – |
| Q4 2016 | $44,000 | -8.3% | 9,417 | +50.0% | 0.00% | – |
| Q3 2016 | $48,000 | +11.6% | 6,278 | -12.6% | 0.00% | – |
| Q2 2016 | $43,000 | -33.8% | 7,185 | 0.0% | 0.00% | – |
| Q1 2016 | $65,000 | +18.2% | 7,185 | +54.4% | 0.00% | – |
| Q4 2015 | $55,000 | +19.6% | 4,653 | 0.0% | 0.00% | – |
| Q3 2015 | $46,000 | -38.7% | 4,653 | 0.0% | 0.00% | – |
| Q2 2015 | $75,000 | 0.0% | 4,653 | 0.0% | 0.00% | – |
| Q1 2015 | $75,000 | -1.3% | 4,653 | 0.0% | 0.00% | – |
| Q4 2014 | $76,000 | +52.0% | 4,653 | 0.0% | 0.00% | – |
| Q3 2014 | $50,000 | – | 4,653 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 1,890,000 | $15,800,400 | 5.14% |
| Ghost Tree Capital, LLC | 1,000,000 | $8,360,000 | 2.75% |
| Soleus Capital Management, L.P. | 2,884,382 | $24,113,434 | 2.22% |
| M28 Capital Management LP | 216,600 | $1,810,776 | 2.08% |
| Paradigm Biocapital Advisors LP | 3,619,015 | $30,254,965 | 2.05% |
| 683 Capital Management, LLC | 1,350,000 | $11,286,000 | 0.88% |
| Parkwood LLC | 165,414 | $6,081 | 0.66% |
| Spotlight Asset Group, Inc. | 79,000 | $660,440 | 0.60% |
| Pier Capital, LLC | 392,709 | $3,283,047 | 0.53% |
| Quantum Private Wealth, LLC | 91,081 | $761,438 | 0.36% |